Ixempra

Indicated For

metastatic breast cancer, platinum-resistant ovarian cancer

About This Medication

# R-Pharm US Access and Support Patient Guide: How to Get Ixempra (ixabepilone) at Low or No Cost Ixempra (ixabepilone) is a chemotherapy medication used to treat certain types of advanced breast cancer, and the **R-Pharm US Access and Support** program from **R-Pharm US** helps eligible patients access it through reimbursement support and assistance for those without active insurance.[1][2][3] ## About Ixempra (ixabepilone) **Ixempra** is an injectable anticancer drug approved for use in combination with capecitabine for metastatic or locally advanced breast cancer in patients whose cancer has progressed after anthracycline and taxane treatments, or as a single agent after these therapies.[7] It works by interfering with cancer cell division, helping to slow tumor growth. Administered intravenously by a healthcare professional, typically every 3 weeks, Ixempra can be expensive without assistance—often thousands of dollars per cycle. This guide explains how the R-Pharm US Access and Support program can reduce or eliminate costs for qualifying patients, making treatment more accessible.[1][2] ## Who Qualifies for the Program? The program supports U.S. patients facing financial barriers to Ixempra. While specific income thresholds are not publicly detailed, patient assistance programs like this generally require you to be a U.S. resident (or Puerto Rico), have limited or no prescription coverage, and meet income guidelines, often based on a percentage of the Federal Poverty Level (FPL).[5] Contact the program for exact criteria, as they assess eligibility case-by-case.[1] Key factors include: - Residency in the U.S. - Financial need (income verification may be required). - Prescription from a licensed healthcare provider. - Medicare or other government insurance may affect eligibility—see insurance section below.[5][6] ## Income Eligibility Breakdown Detailed income limits are not specified in available program information, which is common for reimbursement-focused support programs that evaluate on a case-by-case basis.[1] Many similar programs use FPL thresholds like 400-500% for insured patients or lower for uninsured. Here's a general example table based on typical PAP structures (call (855) 991-7277 to confirm Ixempra specifics): | Household Size | Up to 400% FPL (Example) | Up to 500% FPL (Example) | |----------------|---------------------------|---------------------------| | 1 person | $60,240 | $75,300 | | 2 people | $81,760 | $102,200 | | 3 people | $103,280 | $129,100 | | 4 people | $124,800 | $156,000 | *Note: 2026 FPL values; actual program thresholds may vary. Programs often adjust annually.*[5] ## Insurance Requirements The program **assists with reimbursement** for patients with insurance by reviewing coverage, helping with prior authorizations, claims, and appeals. It also **helps with costs if you have no active insurance**, potentially providing free or low-cost Ixempra.[1][2][3] Medicare patients may qualify for support if they meet income criteria, though some PAPs exclude federal insurance—verify directly. Provide insurance cards during application for benefits investigation.[2][5] ## Step-by-Step Application Process Applications use **multiple methods**: phone, forms, or downloads. Here's how to apply:[1][2][3] 1. **Discuss with your doctor**: Share this guide. Your oncologist or nurse must help complete forms, as a prescription is required.[2] 2. **Download or request forms**: Visit ixempra.com for the **R-Pharm US Access and Support enrollment form** and **patient authorization form**. The enrollment form gathers your info; authorization allows support services.[2][3] 3. **Fill out patient sections**: Provide personal details, income info, insurance status. Sign and date.[2] 4. **Doctor completes their part**: Healthcare provider fills clinical/prescription section and signs.[3] 5. **Gather documents**: May include proof of income (tax returns), residency, insurance cards. Exact list confirmed by program.[5][6] 6. **Submit**: Call **(855) 991-7277** for guidance, fax/mail forms, or follow online instructions. Program contacts your doctor for any missing info.[1][2] 7. **Follow up**: Expect notification on status.[2] Work with your care team—accurate completion is your and your provider's responsibility.[2] ## Timeline and Delivery **Processing time** varies; similar programs review in 1-4 weeks. You'll be notified by phone/email, and your provider too.[2][4] If approved, medication ships to your doctor's office, pharmacy, or directly (details confirmed post-approval). Free drug may come via mail or provider.[1][8] Refills require reauthorization—see FAQ. ## Alternatives if Denied If ineligible: - Appeal with more documentation. - Check **GoodRx** for coupons/savings.[5] - Search Medicare.gov PAP directory or call manufacturer.[5] - Explore **biosimilar alternatives**: None listed for Ixempra.[program data] - State assistance, 340B clinics, or generic options if available. - GoodRx Helps for clinic-based free meds.[5] Contact (855) 991-7277 for denial reasons and next steps. ## Important Disclaimer This guide is for informational purposes based on publicly available data as of 2026. R-Pharm US makes **no guarantee** of reimbursement or approval. Eligibility, benefits, and terms can change—always verify with the program at (855) 991-7277 or ixempra.com. Consult your doctor before starting/stopping treatment. Not legal/financial advice. R-Pharm US not liable for application errors.[2][3] (Word count: 942)

Program information last verified: March 30, 2026